Developer docs
API playgroundTry for free, no card

Search company profiles

SINTX Technologies

Full company profile

uuid0000rs9

Namestring
SINTX Technologies
Legal namestring
SINTX Technologies, Inc.
Websiteurl
sintx.com
Company typeenum
Public
Founded yearint
1996
Descriptiontext

SINTX Technologies, Inc. (NASDAQ: SINT) is a Salt Lake City-based advanced ceramics company founded in 1996 that manufactures silicon nitride (Si3N4) materials and medical devices. Its core platform is proprietary silicon nitride, which combines inherent antibacterial and antiviral properties with osteogenic/osseointegrative performance — features the company positions as differentiated versus PEEK and titanium implants in spine and orthopedic use cases. The company holds FDA 510(k) clearance for spinal implants (commercial use since 2008, 50,000+ implants placed) and for the SINAPTIC Foot & Ankle Osteotomy Wedge System (cleared October 2025), and is expanding into composite 3D printing via an Evonik-supplied silicon nitride-PEEK compound. Its product portfolio spans the Valeo spinal interbody family, SINAPTIC foot and ankle systems, SiNERGY composites, OsseoSculpt biologics, FleX-SN antipathogenic powders, and BoroShock boron carbide industrial ceramics. The company also performs contract advanced-ceramic component manufacturing for OEM customers in aerospace, defense, and industrial markets.

SINTX generates revenue through direct sales of FDA-cleared medical devices to hospitals and orthopedic surgeons, OEM supply agreements (Evonik for SiN/PEEK compound, O2TODAY for antipathogenic face-mask materials), licensing of silicon nitride and antipathogenic fabric IP, distributor relationships for international reach, and contract manufacturing of advanced ceramic components. Pricing for medical devices is not publicly disclosed and is set via GPO contracts and hospital/surgeon negotiations; industrial contract-manufacturing pricing is volume- and complexity-based. The go-to-market combines enterprise field sales to surgical channels, OEM partnerships for material and component supply, and distributor programs for regional coverage in the U.S., Brazil, Europe, and Taiwan. Revenue remains very small (Q1 2026 of $0.38M, Q4 2025 ~$0.30M) as the company transitions from a single-product spinal implant business toward a diversified biomaterials and contract-manufacturing platform, with the SINAPTIC Foot & Ankle launch, OsseoSculpt biologic, and Evonik SiN/PEEK supply agreement representing the principal near-term growth vectors.

Short descriptiontext

SINTX Technologies (NASDAQ: SINT) is a Salt Lake City advanced ceramics company that manufactures silicon nitride medical devices — spinal implants, the SINAPTIC foot and ankle system, antipathogenic powders, and OEM composite materials — and sells to hospitals, surgeons, and industrial customers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSalt Lake City, United States
HQ citystring
Salt Lake City
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
silicon nitride implants, spinal fusion devices, foot ankle reconstruction, antipathogenic materials, advanced ceramic manufacturing
Industry2 codes
PRIMARYHLAHAEAJ
3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAHAEAA
Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
NAICS code2 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Surgical Appliance and Supplies Manufacturing339113
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Orthopedic Medical Devices
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Medical Device Sales
TypeOne Time License
Description

Sale of FDA-cleared silicon nitride medical devices including spinal implants (Valeo line), foot and ankle reconstruction systems (SINAPTIC), and dental implants. Revenue generated from direct hospital and surgeon sales as well as through distribution partnerships.

sintx.com
2Contract Manufacturing
TypeTransaction Fee
Description

Advanced ceramic component manufacturing services for OEM customers. The company secured purchase orders exceeding $3.2 million from multiple contract manufacturing customers for advanced ceramic component production in 2026.

stocktitan.net
3Technology Licensing
TypeLicensing Royalties
Description

Licensing of silicon nitride technology, antipathogenic fabric patents, and composite materials to medical device manufacturers. Company pursued strategic options with Ascendiant Capital Markets as exclusive advisor in 2024.

bulletin.ceramics.org
4Materials Sales
TypeHardware Sales
Description

Sale of silicon nitride powders (FleX-SN-AP for antipathogenic applications) and industrial silicon nitride materials for aerospace, automotive, and industrial manufacturing applications.

sintx.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1SiNAPTIC Surgical
Description

Brand for foot and ankle reconstruction medical devices, acquired July 1, 2025

orthospinenews.com
+5 more records
Core offering1 text field

SINTX Technologies manufactures and sells silicon nitride (Si3N4) advanced ceramic medical devices, including FDA-cleared spinal interbody fusion implants and foot and ankle reconstruction systems, as well as antipathogenic silicon nitride powders (FleX SN-AP) for medical textiles and infection-prevention products. The company also provides silicon nitride–PEEK (SiNERGY) composites for 3D-printed patient-specific implants and contract-manufactured advanced ceramic components for aerospace, defense, and industrial customers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Over 50,000 silicon nitride spinal implants successfully placed since 2008
+3 more records
Product and service8 records
1SINAPTIC Foot & Ankle Osteotomy Wedge System
CategoryOrthopedic Implants
Description

FDA-cleared foot and ankle reconstruction implant system made from silicon nitride biomaterial, designed for orthopedic surgeons performing foot osteotomy and fusion procedures.

2Valeo Spinal Fusion Implants
CategorySpinal Implants
Description

Silicon nitride interbody fusion devices for spinal surgery, including Valeo TL and Valeo II product lines, used by hospitals and orthopedic spine surgeons.

3FleX-SN Medical-Grade Silicon Nitride Materials
CategoryBiomaterials
Description

Medical-grade silicon nitride powder and composite materials used as base biomaterial for implants and as raw input for medical device OEMs.

4FleX SN-AP Antipathogenic Powder
CategoryAntipathogenic Materials
Description

Antipathogenic silicon nitride powder designed to be embedded in fabrics or used as a coating to impart antiviral and antibacterial properties to medical textiles and infection-prevention products.

5SiNERGY SiN/PEEK Composite
CategoryBiomaterials
Description

Proprietary silicon nitride–PEEK composite biomaterial for orthopedic and spinal applications, enabling 3D-printed patient-specific implants with antipathogenic and osteogenic properties.

6OsseoSculpt Biologic Product
CategoryOrthopedic Biologics
Description

Advanced biologic adjunct product used together with the SINAPTIC Foot & Ankle Osteotomy Wedge System to support bone healing in foot and ankle reconstruction procedures.

7Composite 3D Printing / Contract Manufacturing Services
CategoryContract Manufacturing
Description

Custom advanced ceramic component manufacturing service, including ceramic 3D printing of silicon nitride and boron carbide parts, for medical, aerospace, defense, and industrial OEM customers.

8Industrial Ceramic Components (Silicon Nitride and Boron Carbide)
CategoryIndustrial Ceramics
Description

Custom silicon nitride and boron carbide ceramic components (such as ball bearings, radomes, RF windows, engine components, and seals) sold directly to aerospace, defense, and industrial OEM customers.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1Evonik Corporation
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-02
Description

SINTX signed a supply agreement with Evonik to manufacture proprietary silicon nitride-PEEK (SiN/PEEK) compound for AI-assisted additive manufacturing of patient-specific implants. Evonik produces the compound to SINTX's specifications at industrial scale, enabling immediate manufacturing of 3D-printed patient-specific implants. The partnership combines Evonik's PEEK polymer manufacturing expertise with SINTX's silicon nitride biomaterial capabilities.

textileworld.com
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2025-09-01
Description

SINTX acquired SiNAPTIC Surgical, LLC in September 2025 for an undisclosed sum to enhance ceramic additive manufacturing capabilities and accelerate commercialization of silicon nitride-based orthopedic and spinal implant technologies. The acquisition provided the SINAPTIC brand and associated product rights.

3O2TODAY
Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2021-07-14
Description

Partnership to incorporate SINTX's FleX SN-AP silicon nitride antipathogenic powder into fabric fibers for non-woven face mask materials. O2TODAY manufactures and distributes face masks and other textile products using the treated materials.

sintx.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

One of the largest pure-play spinal fusion and orthopedic implant companies, with a deep portfolio of interbody devices and biologics. Directly competes with SINTX's Valeo spinal implant line for hospital and surgeon adoption in spine fusion procedures.

TypeBroad incumbent
Description

Diversified medical device leader with a large spine and orthopedic implant franchise and biologics portfolio. Competes broadly with SINTX in hospital and surgeon channels and sets the benchmark for what scale-driven commercial execution looks like.

TypeBroad incumbent
Description

Global leader in orthopedic reconstruction (hips, knees, extremities) with biomaterials and biologics offerings. Provides the incumbent benchmark in joint replacement implants, the broader category SINTX targets with its silicon nitride materials.

TypeDirect peer
Description

Spine-focused medical device company developing interbody fusion devices, fixation systems, and biologics. Directly comparable to SINTX in targeting spinal fusion surgeons with a differentiated material/biological value proposition.

TypeDirect peer
Description

Spine and orthopedic reconstruction company with biologics, fixation, and extremity reconstruction products. Comparable as a competitor in spinal fusion and emerging extremity reconstruction, the same segments SINTX targets with silicon nitride.

TypeDirect peer
Description

Independent spine company with a portfolio of interbody, fixation, and biologics products. Competes in the same spinal fusion hospital channel as SINTX's Valeo implants and shares a similar focus on surgeon-driven adoption.

TypeEmerging player
Description

PEEK polymer specialist with an Invibio biomaterials division supplying medical-grade PEEK for spinal and orthopedic implants. Directly comparable as SINTX's SiN/PEEK co-development partner with Evonik and a competing biomaterials platform in the same implant applications.

TypeDirect peer
Description

Specialty orthopedic device company using differentiated implant material (titanium-coated silicone for sacroiliac joint fusion). Comparable as a small-cap, single-category orthopedic pure-play with novel-material implants sold through spine/extremity surgeons.

TypeBroad incumbent
Description

Largest spinal implant franchise globally, with INFUSE bone graft and interbody devices. Represents the dominant incumbent that SINTX's Valeo silicon nitride interbody line must compete against for surgeon adoption and hospital contracts.

TypeBroad incumbent
Description

Large advanced ceramics manufacturer with a medical division producing ceramic hip and dental implants (e.g., BIOLOX). Comparable as an established technical ceramics player in medical devices that competes with SINTX in ceramic biomaterials and contract manufacturing.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds19 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SINTX Technologies

Orthopedic Medical Devicessintx.com

SINTX Technologies (NASDAQ: SINT) is a Salt Lake City advanced ceramics company that manufactures silicon nitride medical devices — spinal implants, the SINAPTIC foot and ankle system, antipathogenic powders, and OEM composite materials — and sells to hospitals, surgeons, and industrial customers.

What SINTX Technologies does

SINTX Technologies, Inc. (NASDAQ: SINT) is a Salt Lake City-based advanced ceramics company founded in 1996 that manufactures silicon nitride (Si3N4) materials and medical devices. Its core platform is proprietary silicon nitride, which combines inherent antibacterial and antiviral properties with osteogenic/osseointegrative performance — features the company positions as differentiated versus PEEK and titanium implants in spine and orthopedic use cases. The company holds FDA 510(k) clearance for spinal implants (commercial use since 2008, 50,000+ implants placed) and for the SINAPTIC Foot & Ankle Osteotomy Wedge System (cleared October 2025), and is expanding into composite 3D printing via an Evonik-supplied silicon nitride-PEEK compound. Its product portfolio spans the Valeo spinal interbody family, SINAPTIC foot and ankle systems, SiNERGY composites, OsseoSculpt biologics, FleX-SN antipathogenic powders, and BoroShock boron carbide industrial ceramics. The company also performs contract advanced-ceramic component manufacturing for OEM customers in aerospace, defense, and industrial markets.

SINTX generates revenue through direct sales of FDA-cleared medical devices to hospitals and orthopedic surgeons, OEM supply agreements (Evonik for SiN/PEEK compound, O2TODAY for antipathogenic face-mask materials), licensing of silicon nitride and antipathogenic fabric IP, distributor relationships for international reach, and contract manufacturing of advanced ceramic components. Pricing for medical devices is not publicly disclosed and is set via GPO contracts and hospital/surgeon negotiations; industrial contract-manufacturing pricing is volume- and complexity-based. The go-to-market combines enterprise field sales to surgical channels, OEM partnerships for material and component supply, and distributor programs for regional coverage in the U.S., Brazil, Europe, and Taiwan. Revenue remains very small (Q1 2026 of $0.38M, Q4 2025 ~$0.30M) as the company transitions from a single-product spinal implant business toward a diversified biomaterials and contract-manufacturing platform, with the SINAPTIC Foot & Ankle launch, OsseoSculpt biologic, and Evonik SiN/PEEK supply agreement representing the principal near-term growth vectors.

SINTX Technologies firmographics

Firmographics
Name
SINTX Technologies
Legal name
SINTX Technologies, Inc.
Website
https://sintx.com
Company type
Public
Founded year
1996
Operating status
Operating
Headcount range
51–100 employees
Short description
SINTX Technologies (NASDAQ: SINT) is a Salt Lake City advanced ceramics company that manufactures silicon nitride medical devices — spinal implants, the SINAPTIC foot and ankle system, antipathogenic powders, and OEM composite materials — and sells to hospitals, surgeons, and industrial customers.
Ownership category
akta.pro rank

SINTX Technologies industry classification

Industry
Product category
Orthopedic Medical Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAEAJ
3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAHAEAA
Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)

Keywords

  • Silicon nitride implants
  • Spinal fusion devices
  • Foot ankle reconstruction
  • Antipathogenic materials
  • Advanced ceramic manufacturing

Where SINTX Technologies is headquartered

Location

Headquarters

HQ city
Salt Lake City
HQ country
United States
HQ region
North America

Offices1 record

Markets served

SINTX Technologies business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Medical Device Sales: Sale of FDA-cleared silicon nitride medical devices including spinal implants (Valeo line), foot and ankle reconstruction systems (SINAPTIC), and dental implants. Revenue generated from direct hospital and surgeon sales as well as through distribution partnerships.
  2. Contract Manufacturing: Advanced ceramic component manufacturing services for OEM customers. The company secured purchase orders exceeding $3.2 million from multiple contract manufacturing customers for advanced ceramic component production in 2026.
  3. Technology Licensing: Licensing of silicon nitride technology, antipathogenic fabric patents, and composite materials to medical device manufacturers. Company pursued strategic options with Ascendiant Capital Markets as exclusive advisor in 2024.
  4. Materials Sales: Sale of silicon nitride powders (FleX-SN-AP for antipathogenic applications) and industrial silicon nitride materials for aerospace, automotive, and industrial manufacturing applications.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

SINTX Technologies product offering

Product offering

Core offering

SINTX Technologies manufactures and sells silicon nitride (Si3N4) advanced ceramic medical devices, including FDA-cleared spinal interbody fusion implants and foot and ankle reconstruction systems, as well as antipathogenic silicon nitride powders (FleX SN-AP) for medical textiles and infection-prevention products. The company also provides silicon nitride–PEEK (SiNERGY) composites for 3D-printed patient-specific implants and contract-manufactured advanced ceramic components for aerospace, defense, and industrial customers.

Differentiator

Problem solved

Functional benefit

Brands

  • SiNAPTIC Surgical: Brand for foot and ankle reconstruction medical devices, acquired July 1, 2025
  • OsseoSculpt
  • SiNERGY
  • Valeo
  • FleX-SN
  • BoroShock

Products and services

  • SINAPTIC Foot & Ankle Osteotomy Wedge System FDA-cleared foot and ankle reconstruction implant system made from silicon nitride biomaterial, designed for orthopedic surgeons performing foot osteotomy and fusion procedures.
  • Valeo Spinal Fusion Implants Silicon nitride interbody fusion devices for spinal surgery, including Valeo TL and Valeo II product lines, used by hospitals and orthopedic spine surgeons.
  • FleX-SN Medical-Grade Silicon Nitride Materials Medical-grade silicon nitride powder and composite materials used as base biomaterial for implants and as raw input for medical device OEMs.
  • FleX SN-AP Antipathogenic Powder Antipathogenic silicon nitride powder designed to be embedded in fabrics or used as a coating to impart antiviral and antibacterial properties to medical textiles and infection-prevention products.
  • SiNERGY SiN/PEEK Composite Proprietary silicon nitride–PEEK composite biomaterial for orthopedic and spinal applications, enabling 3D-printed patient-specific implants with antipathogenic and osteogenic properties.
  • OsseoSculpt Biologic Product Advanced biologic adjunct product used together with the SINAPTIC Foot & Ankle Osteotomy Wedge System to support bone healing in foot and ankle reconstruction procedures.
  • Composite 3D Printing / Contract Manufacturing Services Custom advanced ceramic component manufacturing service, including ceramic 3D printing of silicon nitride and boron carbide parts, for medical, aerospace, defense, and industrial OEM customers.
  • Industrial Ceramic Components (Silicon Nitride and Boron Carbide) Custom silicon nitride and boron carbide ceramic components (such as ball bearings, radomes, RF windows, engine components, and seals) sold directly to aerospace, defense, and industrial OEM customers.

Quantifiable outcome

  • Over 50,000 silicon nitride spinal implants successfully placed since 2008
  • +3 more outcomes

Companies that use SINTX Technologies

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

SINTX Technologies technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

SINTX Technologies partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Evonik CorporationcoreStrategic or Co-development Partner · 2 December 2025SINTX signed a supply agreement with Evonik to manufacture proprietary silicon nitride-PEEK (SiN/PEEK) compound for AI-assisted additive manufacturing of patient-specific implants. Evonik produces the compound to SINTX's specifications at industrial scale, enabling immediate manufacturing of 3D-printed patient-specific implants. The partnership combines Evonik's PEEK polymer manufacturing expertise with SINTX's silicon nitride biomaterial capabilities.
  • SiNAPTIC Surgical, LLCcoreOEM/ Whitelabel/ Licensing Partner · 1 September 2025SINTX acquired SiNAPTIC Surgical, LLC in September 2025 for an undisclosed sum to enhance ceramic additive manufacturing capabilities and accelerate commercialization of silicon nitride-based orthopedic and spinal implant technologies. The acquisition provided the SINAPTIC brand and associated product rights.
  • O2TODAYminorChannel Partner/ Reseller/ Distributor · 14 July 2021Partnership to incorporate SINTX's FleX SN-AP silicon nitride antipathogenic powder into fabric fibers for non-woven face mask materials. O2TODAY manufactures and distributes face masks and other textile products using the treated materials.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

SINTX Technologies competitors and assessment

Company assessment

Direct peers

  • Globus Medical (formerly NuVasive): One of the largest pure-play spinal fusion and orthopedic implant companies, with a deep portfolio of interbody devices and biologics. Directly competes with SINTX's Valeo spinal implant line for hospital and surgeon adoption in spine fusion procedures.
  • SeaSpine Holdings: Spine-focused medical device company developing interbody fusion devices, fixation systems, and biologics. Directly comparable to SINTX in targeting spinal fusion surgeons with a differentiated material/biological value proposition.
  • Orthofix Medical: Spine and orthopedic reconstruction company with biologics, fixation, and extremity reconstruction products. Comparable as a competitor in spinal fusion and emerging extremity reconstruction, the same segments SINTX targets with silicon nitride.
  • Alphatec Spine: Independent spine company with a portfolio of interbody, fixation, and biologics products. Competes in the same spinal fusion hospital channel as SINTX's Valeo implants and shares a similar focus on surgeon-driven adoption.
  • SI-BONE: Specialty orthopedic device company using differentiated implant material (titanium-coated silicone for sacroiliac joint fusion). Comparable as a small-cap, single-category orthopedic pure-play with novel-material implants sold through spine/extremity surgeons.

Broad incumbents

  • Stryker: Diversified medical device leader with a large spine and orthopedic implant franchise and biologics portfolio. Competes broadly with SINTX in hospital and surgeon channels and sets the benchmark for what scale-driven commercial execution looks like.
  • Zimmer Biomet: Global leader in orthopedic reconstruction (hips, knees, extremities) with biomaterials and biologics offerings. Provides the incumbent benchmark in joint replacement implants, the broader category SINTX targets with its silicon nitride materials.
  • Medtronic (Spinal & Biologics): Largest spinal implant franchise globally, with INFUSE bone graft and interbody devices. Represents the dominant incumbent that SINTX's Valeo silicon nitride interbody line must compete against for surgeon adoption and hospital contracts.
  • CeramTec: Large advanced ceramics manufacturer with a medical division producing ceramic hip and dental implants (e.g., BIOLOX). Comparable as an established technical ceramics player in medical devices that competes with SINTX in ceramic biomaterials and contract manufacturing.

Emerging players

  • Victrex (Invibio): PEEK polymer specialist with an Invibio biomaterials division supplying medical-grade PEEK for spinal and orthopedic implants. Directly comparable as SINTX's SiN/PEEK co-development partner with Evonik and a competing biomaterials platform in the same implant applications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

SINTX Technologies social profiles

Digital presence

SINTX Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SINTX Technologies leadership team

Management profile

Number of profiles

Profiles14 records

SINTX Technologies subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

SINTX Technologies funding detail

Funding detail

Funding overview

Funding rounds19 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SINTX Technologies M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SINTX Technologies

What does SINTX Technologies do?

SINTX Technologies manufactures and sells silicon nitride (Si3N4) advanced ceramic medical devices, including FDA-cleared spinal interbody fusion implants and foot and ankle reconstruction systems, as well as antipathogenic silicon nitride powders (FleX SN-AP) for medical textiles and infection-prevention products. The company also provides silicon nitride–PEEK (SiNERGY) composites for 3D-printed patient-specific implants and contract-manufactured advanced ceramic components for aerospace, defense, and industrial customers.

Is SINTX Technologies a public or private company?

SINTX Technologies is a public company. It is classified as public and is currently operating.

When was SINTX Technologies founded?

SINTX Technologies was founded in 1996. It employs 51 to 100 people.

Where is SINTX Technologies based?

SINTX Technologies is headquartered in Salt Lake City, United States, in the North America region.

How does SINTX Technologies make money?

Four revenue lines are on record. Medical Device Sales are the primary driver. The others are contract Manufacturing, technology Licensing and materials Sales.

Who are SINTX Technologies's main competitors?

Direct peers on record are Globus Medical (formerly NuVasive), SeaSpine Holdings, Orthofix Medical, Alphatec Spine and SI-BONE. Broad incumbents are Stryker, Zimmer Biomet, Medtronic (Spinal & Biologics) and CeramTec. Victrex (Invibio) is listed as an emerging player.

Does SINTX Technologies have an API?

No public API is recorded for SINTX Technologies.

What industry is SINTX Technologies in?

SINTX Technologies's product category is Orthopedic Medical Devices. Its primary akta.pro industry code is HLAHAEAJ, 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial), with a secondary code of HLAHAEAA, Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Seeking AlphaSintx Technologies, Inc. (SINT) Q3 2026 Earnings Call Prepared Remarks TranscriptSintx Technologies reported its Q3 2026 financial results and filed a Form 10-Q with the SEC. CEO Eric Olson and CFO Kevin Trask provided business and financial updates, including forward-looking statements on revenue, guidance, and commercialization. The company outlined near-term priorities in its closing remarks.NasdaqSINTX Technologies, Inc. Reports Third Quarter 2026 Revenue of approximately $2.2 millionSINTX Technologies reported Q3 2026 revenue of about $2.2 million, up from $208,000 a year earlier, with gross profit of $1.4 million and a net loss of $1.6 million. The company received $2.0 million in warrant proceeds and regained Nasdaq's minimum equity requirement.The future of tradingSINTX Technologies publishes update to financial calendarSINTX Technologies will release its third-quarter 2026 financial results on November 5, 2026, following the market close. A conference call and webcast to review the results will begin at 4:30 p.m. ET that day.American Banking and Market NewsSintx Technologies (NASDAQ:SINT) & Insulet (NASDAQ:PODD) Head to Head ContrastSintx Technologies and Insulet are compared on earnings, valuation, and analyst ratings. Insulet has higher revenue ($2.71B vs $1.02M) and profitability, while Sintx trades at a lower P/E. Analysts favor Sintx with a higher consensus rating and upside, but Insulet beats on 8 of 13 factors.American Banking and Market NewsSintx Technologies (NASDAQ:SINT) & Bioventus (NASDAQ:BVS) Head-To-Head SurveyBioventus and Sintx Technologies are compared on institutional ownership, profitability, and analyst ratings. Bioventus has higher revenue and earnings, but Sintx has a higher upside potential. Bioventus beats Sintx on 11 of 13 factors.Defense WorldAvanos Medical (NYSE:AVNS) and Sintx Technologies (NASDAQ:SINT) Financial AnalysisSintx Technologies and Avanos Medical are compared on valuation, risk, earnings, and analyst ratings. Sintx has a consensus price target of $9.33, implying a 359.77% upside, while Avanos trades at a lower P/E ratio. Sintx beats Avanos on 7 of 13 factors.Defense WorldContrasting Sintx Technologies (NASDAQ:SINT) and electroCore (NASDAQ:ECOR)Sintx Technologies and electroCore are compared on profitability, risk, and analyst ratings. Sintx has a stronger consensus rating and higher upside potential, while electroCore trades at a lower P/E. Sintx beats electroCore on 7 of 13 factors.Markets DailyMedline (NASDAQ:MDLN) versus Sintx Technologies (NASDAQ:SINT) Financial ComparisonMedline and Sintx Technologies are compared on valuation, earnings, and analyst recommendations. Sintx has a higher consensus price target upside (424.34% vs 38.26%) and lower P/E, but Medline beats on 10 of 14 factors. Analysts favor Sintx due to its higher probable upside.American Banking and Market NewsCooper Companies (NASDAQ:COO) and Sintx Technologies (NASDAQ:SINT) Critical AnalysisCooper Companies and Sintx Technologies are compared on profitability, analyst ratings, and valuation. Cooper beats Sintx on 9 of 13 factors, with higher revenue and earnings, while Sintx has a lower P/E ratio. Analysts favor Sintx due to higher upside potential.Ticker ReportAnalyzing Sintx Technologies (NASDAQ:SINT) & Innovative Eyewear (NASDAQ:LUCY)Sintx Technologies beats Innovative Eyewear on 7 of 13 factors, including institutional ownership and analyst ratings. Sintx has a consensus price target of $9.33, implying 455.56% upside, while Innovative Eyewear trades at a lower P/E but lower revenue and earnings.